Navigation Links
Handling HPV vaccines and screening: The views of 100 authors

Amsterdam, 21 September, 2006 - Elsevier is delighted to announce the publication of a unique supplement to the journal Vaccine: HPV Vaccines and Screening in the Prevention of Cervical Cancer. This special monograph provides a comprehensive and invaluable update for paediatricians, gynaecologists, health educators, policy decision makers, industry and major donor institutions worldwide.

With the arrival of the Human Papillomavirus (HPV) vaccines and the progressive introduction of HPV-based screening technology, the field of cervical cancer prevention is expanding into new areas of influence involving an ever-widening group of professionals. Starting with the offer of HPV vaccines to pre-adolescent girls and the optional vaccination of young and middle-age women, HPV vaccines may in some instances be recommended as a universal vaccine for both genders towards the prevention of cervical cancer. "An unprecedented and phenomenal challenge for Public Health in the 21st century", according to Dr. Xavier Bosch, Guest Editor and driving force behind this monograph; "The background, the results, the challenges and a set of proposals are analyzed by a group of 100 independent experts, leaders in the various relevant fields".

This monograph was officially launched during the 23rd International Papillomavirus Conference & Clinical Workshop in Prague, Czech Republic at the beginning of September 2006. The full version is available at the Vaccine website (http://www.elsevier.com/locate/vaccine). Furthermore, this landmark publication will be available via the HINARI programme, the public-private initiative (launched by the World Health Organization) to bridge the digital divide in health information access (http://www.who.int/hinari/en/).


'"/>

Source:Elsevier


Page: 1

Related biology news :

1. Live vaccines more effective against horse herpes virus
2. Designing vaccines by computer
3. Improving the potential of cancer vaccines
4. Report focuses on challenges to unlocking future promise of vaccines
5. Medical experts: US unlikely to have enough vaccines to stop avian flu
6. Plant-derived vaccines safeguard against deadly plague
7. High-dose flu vaccines appear to safely boost immunity in elderly
8. Protecting virus offers instant flu protection and converts flu infections into their own vaccines
9. Super enzyme may lead way to better tumor vaccines
10. Cellulose nanocrystal research could lead to new vaccines, computer inks
11. Cancer vaccines -- Taking a jab at cancer by stimulating the immune system
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/19/2016)... , España y TORONTO , 19 de diciembre ... Northern Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, un ... en varios tipos de tumor en 2017, con múltiples sitios previstos ... ... clase con objetivo en el factor inhibidor de leucemia (LIF), una ...
(Date:12/15/2016)... and BADEN-BADEN, Germany , December ... leading global financial services provider, today announced an agreement with ... behavioural biometrics, to join forces. The partnership will enable clients ... strategies in compliance with local data protection regulation. ... In order to ...
(Date:12/15/2016)... , Dec. 15, 2016  There is much more ... or starting the engine. Continental will demonstrate the intelligence ... Las Vegas . Through the combination of the ... Entry) and biometric elements, the international technology company is ... personalization and authentication. "The integration of biometric ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... MD (PRWEB) , ... January 18, 2017 , ... ... the National Institutes of Health (NIH) to update its Data Sharing Policy. Specifically, ... “scoreable” element of grant applications subject to the existing policy. AMIA recommended that ...
(Date:1/19/2017)... 18, 2017  Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW ... therapies for operable and inoperable solid tumor cancers, announced ... Officer of NW Bio, will present at the Phacilitate ... the Hyatt Regency Hotel in Miami, Florida ... session entitled "New Therapeutic Approaches – Expanding the Reach ...
(Date:1/18/2017)... 2017   Boston Biomedical , an industry leader ... cancer stemness pathways, will feature data from two clinical ... 2017 ASCO Gastrointestinal Cancers Symposium, held from January 19-21, ... Napabucasin is an orally-administered investigational agent designed to ... Cancer stem cells (CSCs) possess the property of stemness ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... and more E&L expertise. Within Albany Molecular Research, Inc. (AMRI), the scientific staff ... past year and is planned for further growth in 2017. Extractable & Leachable ...
Breaking Biology Technology: